B+
Bull case
25%
Probability
Target price
$19.00
Analysis reference price unavailable
Analysis 2026-10-11 · RankAlpha Sentiment Codex
IART
Integra LifeSciencesBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Cash generation and manufacturing recovery could support deleveraging and renewed product availability. Integra maintained an approximately $190 million–$200 million 2026 operating-cash-flow expectation despite lowering revenue and adjusted EPS guidance.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.9.
What can break
Further Cincinnati restoration delays or larger-than-estimated Q4 supply losses. [#SEC-8K-2026-10-02]
Momentum
10
Value
60
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $15.00 · Bull $19.00 · Bear $9.00Analysis 2026-10-11; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-11 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $16.89
Why
Momentum10 · Δ7d -5.3
Value60 · Δ7d +0.9
Sentiment60 · Δ7d +13.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.9.
Contradictions & invalidation
- • Further Cincinnati restoration delays or larger-than-estimated Q4 supply losses. [#SEC-8K-2026-10-02]
- • Insurance recoveries may differ from Integra’s expectation of mitigating a substantial portion of disruption-related earnings impact. [#SEC-8K-2026-10-02]
- • The Cincinnati disruption, reduced outlook and higher refinancing cost compound execution risk.
Catalyst clock
2026-10-21
October 21 results test the revised outlook
Lead driver: Value · See fundamentals
Momentum
10
8% active weight
Current posture
7d trendFlat
Δ7d
-5.3
Δ21d
-22.1
Value
60
47% active weight
Current posture
7d trendFlat
Δ7d
+0.9
Δ21d
+0.5
Sentiment
60
45% active weight
Current posture
7d trendImproving
Δ7d
+13.5
Δ21d
-24.1
Why this grade
Composite grade B. Momentum 10.3 / Value 60.5 / Sentiment 60.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-11. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$15.00
Analysis reference price unavailable
Analysis 2026-10-11 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$9.00
Analysis reference price unavailable
Analysis 2026-10-11 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$926.27M
Beta
1.04
Shares Out
77.77M
P/E (TTM) · Derived
-1.8
P/S (TTM)
0.60
P/FCF (TTM)
65.17
Rev YoY
+0.8%
EPS YoY
-100.9%
Gross Margin
+55.2%
Op Margin
+10.7%
Net Debt
$1.77B
Current Ratio
3.60
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data